Navigating the Landscape of Hierarchical Multi-Component Strategies: GPC, DOOR, and MOST

📅 2026-04-14
📈 Citations: 0
Influential: 0
📄 PDF

career value

183K/year
🤖 AI Summary
This study addresses the ongoing challenge in drug development of integrating and structuring multidimensional patient-centered outcomes to enable comprehensive efficacy evaluation. It systematically compares three hierarchical composite methodologies—Generalized Pairwise Comparisons (GPC), Desirability of Outcome Ranking (DOOR), and the Markov Ordinal State Transition (MOST) model—and, for the first time, establishes their theoretical connections while elucidating fundamental structural and philosophical differences. Through statistical modeling, illustrative case analyses, and methodological comparison, the work clarifies the underlying mechanisms, appropriate use cases, strengths, and limitations of each approach. The findings provide a unified methodological framework to guide the design of patient-centered clinical trials and suggest promising directions for future research in outcome-based therapeutic assessment.

Technology Category

Application Category

📝 Abstract
There is a growing recognition of the importance to involve patients in every stage of drug development. This shift acknowledges that patients' perspectives, experiences, and preferences are essential for ensuring that treatments meet real-world needs. In this context, a new body of statistical literature has emerged, focusing not only on the simultaneous consideration of multiple outcomes that reflect patients' overall experiences, but also on their structured prioritization. We refer to this class of approaches as hierarchical multi-component statistical methods. Among these, two influential frameworks - generalized pairwise comparisons (GPC) and desirability of outcome ranking (DOOR) - have emerged in the last decade, each aiming to offer a comprehensive approach to evaluating treatment effects. A new methodology, referred to here as the Markov ordinal state transition model (MOST), has recently been introduced without focusing on an explicit link with GPC nor DOOR. This paper seeks to fill this gap by offering a comprehensive and comparative analysis of the three approaches. Through examples and an exploration of the structural and philosophical differences between the methods, our aim is to provide guidance and encourage lines of research in the rapidly-evolving landscape of hierarchical multi-component statistical methodologies.
Problem

Research questions and friction points this paper is trying to address.

hierarchical multi-component
generalized pairwise comparisons
desirability of outcome ranking
Markov ordinal state transition model
patient-centered outcomes
Innovation

Methods, ideas, or system contributions that make the work stand out.

hierarchical multi-component methods
generalized pairwise comparisons
desirability of outcome ranking
Markov ordinal state transition model
patient-centered outcomes
M
Mickaël De Backer
UCB, Anderlecht, Belgium
J
Johan Verbeeck
Data Science Institute, I-BioStat, Hasselt University, Diepenbeek, Belgium
V
Vivian Lanius
UCB, Monheim am Rhein, Germany
M
Marc Vandemeulebroecke
Clinical Statistics & Analytics, Statistical Innovation, Bayer BCC AG, Basel, Switzerland
Scott Evans
Scott Evans
Professor, George Washington University
Clinical trialsdiagnosticsinfectious diseases
Toshimitsu Hamasaki
Toshimitsu Hamasaki
The George Washington University Biostatistics Center
Medical StatisticsStatisticsClinical TrialsAdaptive DesignsMultiple Testing
M
Marc Buyse
Data Science Institute, I-BioStat, Hasselt University, Diepenbeek, Belgium; Department of Biostatistics, IDDI (International Drug Development Institute), Ottignies, Belgium; One2Treat, Louvain-la-Neuve, Belgium
F
Frank E. Harrell Jr.
Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA